Trading Update

Plant Health Care PLC 25 January 2006 Embargoed until 07.00 25 January 2006 Plant Health Care plc POST YEAR-END TRADING AND PRODUCT UPDATE Major support for Pre-Tect Product Increasing Interest for Myconate Trading Plant Health Care plc ('PHC' or the 'Company'), a leading provider of natural plant fertility products, is pleased to announce that since the update provided in its interim statement on 19 September 2005, it has continued to make good progress. Although some supplier delays have resulted in sales for the year ended 31 December 2005 being slightly below earlier expectations, better gross margins and cost containment have been achieved which it believes will enable the Company to report in line with expectations, before exceptional items, as previously referred to. The current year has started well, with the John Deere contract now well underway and indications that a number of new agreements will provide significant revenue growth in Europe. The Company has, however, already begun to invest in additional people, mainly in sales, to manage this growth and to move forward some other initiatives, including Pre-Tect and Myconate testing. Major support for Pre-Tect Product The Company is pleased to announce very encouraging results following independent trials of its newly formulated, naturally derived Pre-Tect product. The tests were carried out in the UK on lettuce and spinach crops by several of the UK's largest salad growing companies and took place in several areas with diverse climate and soil conditions. The tests were full farm replicated trials on whole head and cut leaf salads. Pre-Tect consistently increased the shelf life of the crops by 25% to 40% (3-5 days). Based on these trials, PHC has entered into supply agreements with several of the largest European salad growers. Additionally, one of the largest supermarket chains in the UK is specifying the use of Pre-Tect on all its salad crop purchases. Increasing Interest for Myconate PHC reported on the early results of its Myconate testing on 15 December 2005 and still has tests ongoing with some of the world's largest agro chemical and seed companies. Mainly as a result of the trials that have already been completed in France, the largest corn growing country in Europe, a number of major seed companies have expressed interest in expanding trials in 2006 and have made initial enquiries about entering into distribution agreements. The Board is of the view that it should not consider any such arrangements until after completion of all the existing trials. At that time the Company will be in a better position to determine the most commercially advantageous routes to market for this product. PHC is currently reviewing various options for the development and commercialisation of Myconate, which, it believes, will have applications across a wide range of the world's most valuable crops and agricultural plants, in particular maize and soybean, the two highest value row crops in the world. PHC expects to release its full year results early March 2006 and it will then provide a further update on the status of the ongoing Myconate trials. For further information please contact: John Brady Jeremy Carey / Christian Taylor-Wilkinson Plant Health Care Tavistock Communications Tel: 020 7920 3150 (on 25/26 January) Tel: 020 7920 3150 Tel: 001 6035253702 (thereafter) This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings